Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877)

Shanghai Junshi Biosciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	26,718	39,550	64,674	69,569	76,812	20,937
Market Cap Growth	-14.33%	-38.85%	-7.04%	-9.43%	266.88%	13.79%
Enterprise Value	26,539	36,993	63,269	66,516	73,113	19,255
Last Close Price	12.38	19.44	48.50	58.00	56.80	26.70
PS Ratio	6.17	23.89	39.36	14.08	40.55	24.15
PB Ratio	0.40	4.90	5.85	6.81	11.10	6.28
P/TBV Ratio	4.86	5.44	6.24	7.38	11.42	6.60
EV/Sales Ratio	13.41	22.35	38.50	13.46	38.60	22.21
Debt / Equity Ratio	0.44	0.24	0.14	0.08	0.15	0.29
Asset Turnover	0.16	0.13	0.12	0.42	0.26	0.18
Inventory Turnover	0.95	1.12	0.97	3.04	1.44	0.79
Quick Ratio	1.62	1.91	3.56	2.42	2.77	2.41
Current Ratio	2.00	2.28	4.09	2.92	3.19	3.31
Return on Equity (ROE)	-26.94%	-29.66%	-28.56%	-10.33%	-37.90%	-23.74%
Return on Assets (ROA)	-10.52%	-12.95%	-14.56%	-4.51%	-17.07%	-11.62%
Return on Capital (ROIC)	-12.49%	-15.32%	-17.14%	-5.49%	-20.14%	-13.03%
Earnings Yield	-6.57%	-6.36%	-4.17%	-1.27%	-2.58%	-3.99%
FCF Yield	-8.39%	-7.90%	-3.79%	-2.66%	-3.15%	-10.91%
Buyback Yield / Dilution	-1.33%	-7.16%	-3.20%	-8.28%	-5.58%	-29.35%
Total Shareholder Return	-1.33%	-7.16%	-3.20%	-8.28%	-5.58%	-29.35%

Source: S&P Capital IQ. Standard template. Financial Sources.